Date published: 2026-3-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Palmityl palmitate (CAS 540-10-3)

0.0(0)
Write a reviewAsk a question

Alternate Names:
Cetyl palmitate
CAS Number:
540-10-3
Purity:
≥95%
Molecular Weight:
480.85
Molecular Formula:
C32H64O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Palmityl palmitate, a saturated fatty acid ester, has been a subject of significant scientific research, particularly in the fields of lipid metabolism, biochemistry, and cosmetic science. Its mechanism of action primarily involves its role as a lipid component in biological membranes and as a precursor in lipid biosynthesis pathways. In research, palmityl palmitate has been investigated for its involvement in cellular processes such as membrane fluidity regulation, signal transduction, and energy storage. Studies have explaind its impact on membrane structure and function, highlighting its importance in maintaining cellular integrity and homeostasis. Additionally, palmityl palmitate serves as a key ingredient in cosmetic formulations, where it acts as an emollient, moisturizer, and skin-conditioning agent. Research efforts have focused on its role in enhancing skin barrier function, improving hydration levels, and reducing transepidermal water loss, contributing to its widespread use in skincare products. Furthermore, palmityl palmitate derivatives have been explored for their potential applications in pharmaceutical formulations, nanoparticle synthesis, and biomaterials engineering, offering opportunities for the development of novel drug delivery systems and functional materials. Overall, palmityl palmitate represents a versatile compound with diverse research applications in lipid biology, cosmetic science, and materials engineering.


Palmityl palmitate (CAS 540-10-3) References

  1. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.  |  Teeranachaideekul, V., et al. 2007. Eur J Pharm Biopharm. 67: 141-8. PMID: 17346953
  2. The effect of cetyl palmitate crystallinity on physical properties of gamma-oryzanol encapsulated in solid lipid nanoparticles.  |  Ruktanonchai, U., et al. 2008. Nanotechnology. 19: 095701. PMID: 21817683
  3. Dissolution of solid lipid extrudates in biorelevant media.  |  Witzleb, R., et al. 2012. Int J Pharm. 422: 116-24. PMID: 22044538
  4. Liquid Crystal Formation from Sunflower Oil: Long Term Stability Studies.  |  da Rocha-Filho, PA., et al. 2016. Molecules. 21: PMID: 27294894
  5. Praziquantel-Solid Lipid Nanoparticles Produced by Supercritical Carbon Dioxide Extraction: Physicochemical Characterization, Release Profile, and Cytotoxicity.  |  Andrade, LN., et al. 2019. Molecules. 24: PMID: 31661906
  6. Preparation and Evaluation of Nanostructured Lipid Carrier for Topical Delivery of Velutin: Synthetic Tyrosinase Inhibitor.  |  Cheon, SH., et al. 2021. J Nanosci Nanotechnol. 21: 4093-4097. PMID: 33715752
  7. Systematic Characterization of Nanostructured Lipid Carriers from Cetyl Palmitate/Caprylic Triglyceride/Tween 80 Mixtures in an Aqueous Environment.  |  Izza, N., et al. 2021. Langmuir. 37: 4284-4293. PMID: 33797256
  8. Brain-targeted, drug-loaded solid lipid nanoparticles against glioblastoma cells in culture.  |  Ak, G., et al. 2021. Colloids Surf B Biointerfaces. 206: 111946. PMID: 34216850
  9. Design expert assisted formulation, characterization and optimization of microemulsion based solid lipid nanoparticles of repaglinide.  |  Maddiboyina, B., et al. 2021. Prog Biomater. 10: 309-320. PMID: 34813041
  10. Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin.  |  Zöller, K., et al. 2022. Eur J Pharm Biopharm. 176: 32-42. PMID: 35584719

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Palmityl palmitate, 100 mg

sc-215671
100 mg
$94.00

Palmityl palmitate, 1 g

sc-215671A
1 g
$454.00